NCT03047642 - Validation of Promising Biomarker Assays to Assess Their Diagnostic Performance Characteristics | Biotech Hunter

Enrollment

2,000

Participants

Timeline

Start Date

April 27, 2017

Primary Completion Date

October 27, 2018

Study Completion Date

November 27, 2019

Conditions

Acute Febrile Illnesses

Interventions

DIAGNOSTIC_TEST

Biomarker assay

There is no intervention on the patients but biomarker assays are being evaluated for their performance to distinguish bacterial infection from non-bacterial infections in febrile patients

Trial Locations (3)

Unknown

Instituto Nacional de Infectologia Evandro Chagas - Fiocruz (INIEC), Rio de Janeiro

CERMEL, Lambaréné

Karonga Prevention Study, Chilumba

All Listed Sponsors

collaborator

Malawi Epidemiology and Intervention Research Unit

OTHER

collaborator

Instituto Nacional de Infectologia Evandro Chagas

UNKNOWN

collaborator

Centre de Recherche Médicale de Lambaréné

OTHER

lead

Foundation for Innovative New Diagnostics, Switzerland

OTHER